New hip implant under surveillance: will it last?
NCT ID NCT02748408
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study is tracking 550 adults aged 18–75 who receive the Medacta SMS femoral stem during total hip replacement. Researchers will monitor how long the implant lasts, how well the hip functions, patient satisfaction, and quality of life. The goal is to confirm the device's safety and performance in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bürgerspital Solothurn
RECRUITINGSolothurn, CH-4500, Switzerland
Contact
-
Herz-Jesu Krankenhaus
RECRUITINGVienna, 1030, Austria
Contact
-
Istituto Ortopedico Galezzi
RECRUITINGMilan, Milan, 20161, Italy
Contact
-
The Elective Orthopaedic Centre (EOC)
RECRUITINGEpsom, Surrey, KT18 7EG, United Kingdom
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SMS femoral stem (a metal hip implant device)
What this could lead to
If successful, this study will confirm that the Medacta SMS hip stem is safe and effective for long-term use in hip replacement patients.
What could go wrong
This is an observational surveillance study, not a controlled trial, so results may be influenced by patient differences. Some patients may experience implant loosening, infection, or need revision surgery.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.